Skip to main content

Table 1 Baseline demographic and clinical characteristics of the three groups

From: Intravenous iron and erythropoietin therapy for postoperative anemia among orthopedic surgery patients

Characteristics

Group 1

(n = 30)

Group 2

(n = 30)

Control

(n = 29)

p value

Gender

    

 Female

19 (63.33%)

12 (40%)

16 (55.17%)

 

 Male

11 (36.67%)

18 (60%)

13 (44.83%)

 

Age (year)

52.6 (27–70)

53.5 (25–70)

52.8 (24–70)

 

Type of surgery

    

 Arthroplasty

5

7

8

 

 Total hip replacement

8

9

6

 

 Total knee replacement

9

8

9

 

 Lumbar laminectomy

9

6

6

 

Hb (g/L)

140 (120–159)

127 (120–139)

132 (120–146)

0.065*, 0.073&, 0.056#

Reticulocyte count

0.058 ± 0.005

0.049 ± 0.007

0.042 ± 0.003

0.067*, 0.073&, 0.231#

CRP (mg/L)

3.11 (3.01–6.49)

3.53 (2.78–5.82)

3.26 (2.73–6.31)

0.083*, 0.062&, 0.143#

Intraoperative blood loss (mL)

628 (400–1000)

743 (200–1200)

659 (200–1500)

0.086*, 0.073&, 0.052#

Postoperative blood loss (mL)

64 (50–150)

71 (50–150)

59 (50–150)

0.354*, 0.421&, 0.653#

  1. Treatment regimens: Group 1, IV iron monotherapy; Group 2, combined IV iron and rHuEPO therapy; and Control, placebo
  2. *Comparison between Group 1 and Control
  3. &Comparison between Group 2 and Control
  4. #Comparison between Group 1 and Group 2